JAK-STAT pathway activation in COPD

Eur Respir J. 2015 Sep;46(3):843-5. doi: 10.1183/09031936.00228414. Epub 2015 Jun 25.

Authors

Liang Yew-Booth¹, Mark A Birrell¹, Ming Sum Lau¹, Katie Baker¹, Victoria Jones¹, Iain Kilty², Maria G Belvisi³

Affiliations

¹ Respiratory Pharmacology, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.
² Pfizer Inc., Cambridge, MA, USA.
³ Respiratory Pharmacology, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK m.belvisi@imperial.ac.uk.

PMID: 26113679
DOI: 10.1183/09031936.00228414

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Blotting, Western
Case-Control Studies
Female
Gene Expression Regulation*
Humans
Immunohistochemistry
Janus Kinases / genetics*
Male
Phosphorylation / physiology
Pulmonary Disease, Chronic Obstructive / genetics*
Pulmonary Disease, Chronic Obstructive / pathology
STAT3 Transcription Factor / genetics*
Sampling Studies
Severity of Illness Index
Signal Transduction / genetics
Smoking / adverse effects
Tissue Culture Techniques

Substances

STAT3 Transcription Factor
Janus Kinases